GERD/GASTRO-ESOPHAGEALREFLUXalso see BOWEL DISORDERS

 

Cannabinoid1 receptor in the dorsal vagal complex modulates lower oesophageal sphincter relaxation in ferrets  (full – 2003)                                                     http://jp.physoc.org/content/550/1/149.full

 

Cannabinoids for gastrointestinal diseases: potential therapeutic applications. (abst – 2003)                                         http://www.ncbi.nlm.nih.gov/pubmed/12517253

 

Involvement of cannabinoid receptors in gut motility and visceral perception (full – 2004)                                           http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574910/?tool=pmcentrez

 

Cannabinoid CB(2) receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux.                                                      (abst – 2007)  http://www.ncbi.nlm.nih.gov/pubmed/17643417

 

Effect of Δ9-tetrahydrocannabinol, a cannabinoid receptor agonist, on the triggering of transient lower oesophageal sphincter relaxations in dogs and humans (full – 2008)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697772/?tool=pmcentrez

 

 

 

 

 

 

 

 

 

Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects      (abst – 2008)                                 http://gut.bmj.com/content/57/8/1140.abstract

 

Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and non- erosive gastro-oesophageal reflux disease.                                                                   (abst – 2010)  http://www.ncbi.nlm.nih.gov/pubmed/20497140

 

Beyond acid suppression: new pharmacologic approaches for treatment of GERD. (abst – 2010)                                           http://www.ncbi.nlm.nih.gov/pubmed/20425477

 

The Gastrointestinal Pharmacology of Cannabinoids: Focus on Motility.                    (full – 2012)

http://content.karger.com/produktedb/produkte.asp?DOI=000339072&typ=pdf

 

Localization of mGluR5, GABA(B) , GABA(A) , and cannabinoid receptors on the vago- vagal reflex pathway responsible for transient lower esophageal sphincter relaxation in humans: an immunohistochemical study.                                                                                       (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22256945

 

Discovery of agonists of cannabinoid receptor 1 with restricted CNS penetration aimed for treatment of gastroesophageal reflux disease.                                                (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/23227781

 

Share a link for